Targeted Endogenous Bioelectric Modulation in Autism Spectrum Disorder: Real-World Clinical Outcomes of the REAC BWO...

Area of Science:

• Neuroscience
• Developmental Pediatrics
• Biomedical Engineering

Background:

• Autism Spectrum Disorder (ASD) is linked to atypical brain activity and connectivity, affecting sensory, social, and behavioral functions.
• Current understanding of ASD pathophysiology highlights the need for novel therapeutic interventions targeting neural network dynamics.

Purpose of the Study:

• To evaluate the efficacy and safety of the Brain Wave Optimization Neurodevelopment-Autism (BWO ND-A) protocol in children with ASD.
• To assess the impact of the BWO ND-A protocol on Autism Treatment Evaluation Checklist (ATEC) scores.

Main Methods:

• A retrospective, single-arm study involving 39 children diagnosed with ASD.
• Participants underwent a preparatory Neuro Postural Optimization (NPO) session followed by 18 sessions of the BWO ND-A protocol using Radio Electric Asymmetric Conveyer (REAC) technology.
• The BWO ND-A protocol involved short daily sessions administered over approximately two weeks.

Main Results:

• A statistically significant reduction in the total Autism Treatment Evaluation Checklist (ATEC) score was observed (mean change -11.51, p < 0.0001).
• 59% of participants showed clinically meaningful improvement (≥8-point ATEC reduction).
• A small percentage (10.3%) exhibited apparent worsening on caregiver ratings, potentially due to transient functional re-adaptation, with no observed adverse effects.

Conclusions:

• The BWO ND-A protocol demonstrates potential for short-term efficacy and safety in improving ASD symptoms in a real-world setting.
• Limitations include the lack of a control group, objective neurophysiological measures, and long-term follow-up.
• Further controlled trials incorporating neurophysiological monitoring are recommended to validate the neuromodulatory effects and their durability.